Rosavin improves insulin resistance and alleviates hepatic and kidney damage via modulating the cGAS-STING pathway and autophagy signaling in HFD/STZ-induced T2DM animals

• Published in: MedChemComm Vol. 15; no. 6; pp. 2098 - 2113
• Main Authors: Ali, Hebatallah S, Al-Amodi, Hiba S, Hamady, Shaimaa, Roushdy, Marian M S, Helmy Hasanin, Amany, Ellithy, Ghada, Elmansy, Rasha A, Ahmed, Hagir H T, Ahmed, Enshrah M E, Elzoghby, Doaa M A, Kamel, Hala F M, Hassan, Ghida, ELsawi, Hind A, Farid, Laila M, Abouelkhair, Mariam B, Habib, Eman K, Elesawi, Mohamed, Fikry, Heba, Saleh, Lobna A, Matboli, Marwa
• Format: Journal Article
• Language: English
• Published: England Royal Society of Chemistry 19.06.2024
• Subjects: Adipose tissue; Animal models; Animals; Autophagy; Damage; Diabetes mellitus; Diabetes mellitus (non-insulin dependent); Epigenetics; High fat diet; Inflammation; Insulin; Insulin resistance; Kidneys; Lipids; Liver; Non-coding RNA; Signatures; Streptozocin; Tumor necrosis factor-α; Weight loss
• ISSN: 2632-8682; 2040-2503; 2632-8682; 2040-2511
• DOI: 10.1039/d4md00023d

: Inflammation-mediated insulin resistance in type 2 diabetes mellitus (T2DM) increases complications, necessitating investigation of its mechanism to find new safe therapies. This study investigated the effect of rosavin on the autophagy and the cGAS-STING pathway-related signatures (ZBP1, STING1, DDX58, LC3B, TNF-α) and on their epigenetic modifiers (miR-1976 and lncRNA AC074117.2) that were identified from analysis in T2DM animals. : A T2DM rat model was established by combining a high-fat diet (HFD) and streptozotocin (STZ). After four weeks from T2DM induction, HFD/STZ-induced T2DM rats were subdivided into an untreated group (T2DM group) and three treated groups which received 10, 20, or 30 mg per kg of daily for 4 weeks. : The study found that rosavin can affect the cGAS-STING pathway-related RNA signatures by decreasing the expressions of ZBP1, STING1, DDX58, and miR-1976 while increasing the lncRNA AC074117.2 level in the liver, kidney, and adipose tissues. Rosavin prevented further weight loss, reduced serum insulin and glucose, improved insulin resistance and the lipid panel, and mitigated liver and kidney damage compared to the untreated T2DM group. The treatment also resulted in reduced inflammation levels and improved autophagy manifested by decreased immunostaining of TNF-α and increased immunostaining of LC3B in the liver and kidneys of the treated T2DM rats. : Rosavin has shown potential in attenuating T2DM, inhibiting inflammation in the liver and kidneys, and improving metabolic disturbances in a T2DM animal model. The observed effect was linked to the activation of autophagy and suppression of the cGAS-STING pathway.